BBTech Digital Research Lab
===========================
A Fundable, Software-Native Research Infrastructure

Vision
------
BBTech is a digital research lab positioned at the intersection of sports analytics,
systems biology, and clinical decision-support. We use basketball as a structured modeling
language to design metrics, experiments, and digital trials for real biological and clinical questions.

Mission: Build a Basketball-to-Biotech OS that turns game analytics concepts (players, archetypes,
playbooks, seasons) into formal models, simulations, and decision tools.

Differentiator: BBTech already has a structured cancer and commercial stack (TER, Four Factors,
CIS, GenomeOS, BioBriefs) that proves the translation is more than a gimmick -- it is a working,
auditable, reproducible research system.

---

Core Scientific Questions
-------------------------
BBTech anchors around real, fundable research questions:

1. Adaptive Therapy & Evolution
   How do different "lineups" of drugs and doses slow or prevent resistance in cancer
   or infectious disease?
   
   BBTech Advantage: Stackelberg game-theory models, R0/SVI infection dynamics, and archetype
   interaction simulations already built into the platform.

2. Spatial Ecology of Disease
   How do immune cells and tumor cells "guard" space, like defenders and scorers on a court?
   
   BBTech Advantage: Spatial shot chart mappers and immune exclusion analogies give a
   natural entry point for tumor microenvironment modeling.

3. Patient Engagement & Behavior
   How do we turn patients into active players in their care through gamified metrics
   (Defensive Rating, Pace, XP, season outcomes)?
   
   BBTech Advantage: CIS (Cancer Information System) and GenomeOS interfaces already
   prototype this concept.

4. Methodology Pitch to Funders
   "We use a sports analytics OS to design, simulate, and validate treatment strategies
   and patient-engagement tools faster and more transparently than traditional pipelines."

---

Technical Architecture
----------------------
BBTech operates as a three-layer digital research infrastructure:

Layer 1: Statistical Translation Engine (The Analyst)
  - Ingests biological data (omics, pathology, clinical stats)
  - Outputs Basketball Codex metrics: TER, Trueness, Flow, R0, SVI, Gravity, etc.
  - Tech focus: Data pipelines, model zoo (Naive Bayes, PK models, spatial stats),
    metric definers and validators.

Layer 2: Strategic Optimization Core (The Coach)
  - Hosts simulation and game-theory engines: Stackelberg solvers, swarm optimizers,
    agent-based scrimmages.
  - Designs therapy "game plans" and tests Playbook Systems.
  - Tech focus: Optimization frameworks, ABMs (Mesa), scenario runners, hyperparameter sweeps.

Layer 3: Public & Clinical Interfaces (The Arena)
  - CIS app, GenomeOS, dashboards, and future tools where patients, clinicians, and
    researchers see scores, seasons, and playbooks.
  - Tech focus: UX, explainability, consent/ledger layer, data export for external researchers.

Together, these layers form a modern digital research infrastructure rather than a single app.

---

Data & Validation Pipelines
---------------------------
Fundable labs need data discipline and verification:

Data Ingestion:
  - Supported inputs: De-identified clinical datasets, public cancer datasets,
    wearables (for CIS), synthetic benchmarks.
  - Standardized schema: bio_datasets, bio_overlays with Arrow-serialized payloads
    and overlays for computed metrics.

Computation + Ledger:
  - Every compute call (Analytics Engine, BioBrief) writes a ledger record with
    tx_hash, payload, compute time, and parameters.
  - Built-in provenance and reproducibility layer -- huge selling point for funders.

Validation Loops:
  - Internal validation: Parameter sweeps, cross-validation, stress tests of new metrics
    (Infection Rate, Mutation Complexity Index, etc.) on benchmark datasets.
  - External validation: Run 90-day pilots with partners (clinical group, biotech)
    to prove reductions in time-to-decision and alignment with expert judgments.
  - Target: 25-35% prioritization speed improvement, as outlined in existing pilot documents.

---

Organizational Structure
------------------------
BBTech operates like a software-first lab with defined roles:

Core Scientific Roles:
  - Systems Biology Lead
    Owns mapping between basketball metrics and biological phenomena.
    Defines hypotheses and experiments.
  
  - Clinical Liaison / PI
    Co-authors protocols, ensures work aligns with real-world clinical decisions
    and regulatory norms.

Technical Roles:
  - Data Engineer
    Builds and maintains ingestion, schema, and caching pipelines.
  
  - ML / Analytics Engineer
    Implements and tests Codex formulas, TER, spatial mappings, Naive Bayes,
    game-theory solvers.
  
  - DevOps / Infra
    Maintains API, UI, ledger, permissions, and environment verification scripts
    (like the NBA-Analog Bio-OS verification script).

Lab Operations:
  - Experiment Coordinator
    Sets schedules for pilots, runs verification scripts, manages SOWs,
    tracks success metrics (time to first BioBrief, Trueness coverage, ledger completeness).

This is a nimble, software-first lab model vs. traditional wet-lab, attractive to
tech-bio investors and certain grantmakers.

---

Research Assets & Outputs
-------------------------
BBTech produces well-defined outputs that look like publications, protocols, and tools:

Scientific Outputs:
  - BBTech BioBriefs
    Structured, reproducible reports with ledger-backed provenance trail.
    Similar to a digital paper per target.
  
  - Preprints / Papers describing:
    - TER & basketball-inspired metrics applied to specific cancers.
    - Game-theoretic therapy schedules vs. standard-of-care.
    - Patient engagement outcomes from CIS / GenomeOS-like tools.

Methodology Outputs:
  - The Playbook Series
    Open or semi-open protocols for systems design, simulation, and analysis.
  
  - Internal RFCs
    Design docs for new archetypes, new metrics, and new "seasons" of experiments.

Software Outputs:
  - Open-source modules (or partially open) for metric calculation, simulation components,
    and visualizations.
  - Closed-core IP around specific clinical decision-support workflows and optimization strategies.

---

Funding & Milestone Roadmap
---------------------------
Investors and grantmakers need a clean roadmap. BBTech operates in phases:

Phase 0: Foundational Platform (Complete)
  Goal: Harden existing Analytics Engine, BioBrief API, ledger integration,
  and minimal CIS/GenomeOS interface.
  
  Evidence: Working end-to-end verification (compute → BioBrief → ledger),
  with demo targets (e.g., KRAS G12C).
  
  Status: DONE. Existing repo structure proves this phase.

Phase 1: Clinical/Biotech Pilot (In Progress)
  Goal: Run at least one 90-day pilot with a partner (academic lab, clinic, biotech)
  using existing SOW-style structure.
  
  KPIs:
    - Time-to-decision reduction
    - Trueness coverage
    - Ledger completeness
    - Expert satisfaction
    - ROI estimates (≥3× investment)
  
  Timeline: 2026 Q2-Q3

Phase 2: Lab Formalization (Next)
  Goal: Stand up BBTech as a named digital lab with:
    - Defined steering committee
    - Advisory board
    - IRB/ethics pathways if needed
    - Clear data-governance policy
  
  KPIs:
    - Number of validated BioBriefs
    - Published or submitted papers
    - Number of Playbook Systems in active research use
  
  Timeline: 2026 Q4

Phase 3: Expansion & Fundraise (Future)
  Goal: Raise a seed/grant round specifically to:
    - Expand archetype catalog and Playbook volumes
    - Add more disease areas (autoimmune, cardio)
    - Add more interfaces (CIS expansions)
    - Hire 2-4 core lab staff around existing code and documents
  
  Timeline: 2027 Q1-Q2

---

Funding Strategy
----------------
BBTech targets multiple funding sources:

1. Grant Funding
   - NIH/NCI: Systems biology, adaptive therapy, patient engagement
   - NSF: Computational methods, game theory, decision science
   - Private foundations: Cancer research, health equity, digital health
   
   Advantage: Reproducibility layer (ledger + Codex) aligns with open-science mandates.

2. Biotech/Pharma Partnerships
   - Pilot contracts for specific targets or indications
   - BioBrief generation as a service
   - Playbook licensing for internal decision-support
   
   Advantage: Fast turnaround (90-day pilots), clear ROI metrics.

3. Venture Investment
   - Tech-bio seed round for scaling infrastructure and team
   - Focus on CIS/GenomeOS commercial potential
   - Pitch: "GitHub for cancer therapy design"
   
   Advantage: Software-native, scalable, ledger-backed IP.

---

How The Playbook Series Ties It Together
-----------------------------------------
The Playbook Series is BBTech's formal protocol library and core lab asset:

- Each Playbook volume encodes a system: which archetypes, metrics, and solvers
  to use for a given class of biological problem.
- Contains reproducible steps: data requirements, model choices, parameter ranges,
  and how to interpret outputs.
- Makes the lab's methods something any collaborating lab can implement.

As a Lab Asset:
  - Scientific artifact (methods section in book form)
  - Commercial artifact (educational product, developer manual for APIs,
    on-ramp for new research partners)

For Funding:
  "BBTech is building a standardized playbook for digital experiments in oncology
  and beyond, backed by a live Analytics Engine, ledger, and public-facing tools
  like CIS and GenomeOS."

---

Key Differentiators for Funders
-------------------------------
1. Built-In Reproducibility
   Every experiment is ledger-logged with tx_hash and parameters.
   Replay any analysis from ledger records.

2. Transparent Metrics
   All metrics (TER, Trueness, Flow, Gravity, archetype-specific) have
   explicit formulas and validation criteria.

3. Familiar Language
   Basketball language makes complex systems biology accessible to patients,
   clinicians, and interdisciplinary teams.

4. Fast Iteration
   90-day pilot structure proves value quickly vs. multi-year traditional studies.

5. Scalable Infrastructure
   Software-native design means marginal cost per new target or partner is low.

---

Partnership Opportunities
-------------------------
BBTech is open to partnerships with:
  - Academic medical centers (clinical pilots, patient recruitment)
  - Biotech companies (target prioritization, therapy design)
  - Pharma (adaptive therapy trials, patient engagement tools)
  - Health systems (CIS deployment, patient outcomes tracking)
  - Funders (grants, venture, impact investing)

Contact: See repo README for contact information.

---

Conclusion
----------
BBTech Digital Research Lab is a fundable, software-native infrastructure for
biological and clinical research using basketball as a structured modeling language.

We have:
  - Proven technical stack (Analytics Engine, BioBrief, Codex, Ledger)
  - Clear scientific questions (adaptive therapy, spatial ecology, patient engagement)
  - Reproducible protocol library (The Playbook Series)
  - Validation framework (90-day pilots, ledger provenance)
  - Organizational structure (defined roles, clear milestones)
  - Multiple funding pathways (grants, partnerships, venture)

BBTech is ready to scale from prototype to production digital lab.

---

Status: Active
Version: 1.0
Authored by: BBTech Research Lab
Last updated: 2026
